Your browser doesn't support javascript.
loading
Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor.
Obchoei, Sumalee; Detarya, Marutpong; Boonnate, Piyanard; Saranaruk, Paksiree; Vaeteewoottacharn, Kulthida; Mahalapbutr, Panupong; Okada, Seiji; Wongkham, Sopit.
Afiliação
  • Obchoei S; Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Songkhla 90110, Thailand.
  • Detarya M; Department of Biochemistry, Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Boonnate P; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Saranaruk P; Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection and Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-0811 Japan.
  • Vaeteewoottacharn K; Department of Biochemistry, Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Mahalapbutr P; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Okada S; Department of Biochemistry, Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Wongkham S; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
Asian Pac J Cancer Prev ; 23(10): 3379-3386, 2022 Oct 01.
Article em En | MEDLINE | ID: mdl-36308362

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article